Skip to content
Shuttingdown

BioRestorative Therapies, Inc.

Services-Misc Health & Allied Services, NEC · MELVILLE

Distress signal

Moderate confidence (50%)

Updated Oct 20, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: BioRestorative Therapies, Inc. received a delisting notice from its exchange (Aug 21, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. BioRestorative Therapies, Inc. received a delisting notice from its exchange

    Aug 21, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 21, 2026, BioRestorative Therapies, Inc. (the Company ) received a delinquency notification letter (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, as a result of the Company s inability to timely file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026 (the Form 10-Q ), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely…”

Company information

Founded
—
Employees (estimate)
—
Industry
Services-Misc Health & Allied Services, NEC
Subindustry
—
Listing
SEC lists the ticker BRTX on Nasdaq.
SEC CIK
0001505497
Website
—
LinkedIn
—
Headquarters
MELVILLE
Also known as
Stem Cell Assurance, Inc.
Legal entities
BioRestorative Therapies, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    BioRestorative Therapies, Inc. — Services-Misc Health & Allied Services, NEC (SIC 8090) — MELVILLE, NY
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 21, 2026, BioRestorative Therapies, Inc. (the Company ) received a delinquency notification letter (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, as a result of the Company s inability to timely file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026 (the Form 10-Q ), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 12:09 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.